ASeq Newsletter

ASeq Newsletter

Share this post

ASeq Newsletter
ASeq Newsletter
T2 Biosystems

T2 Biosystems

Mar 11, 2025
∙ Paid
1

Share this post

ASeq Newsletter
ASeq Newsletter
T2 Biosystems
1
Share

Genomeweb has and interesting article pondering the demise of T2 Biosystems. But the story of molecular test to replace blood culture failing to gain traction doesn’t seem particularly mystifying to me.

The companies annual revenue appears to have reached ~$8M in 2024, 2023s was $7.2M so this wasn’t accelerating particularly quickly. They were operating at a loss of $50.1M in 2023, pretty typical for a startup like this. What’s a little odd is that “Cost of Product” was routinely double “product revenue”1:

Technology

T2s technology was based on detection of magnetic nano-particles. In general it appears to work as described below, do RT-PCR (on instrument) beads capture the target DNA then these DNA labelled magnetic nano-particles come in and hybridize:

This post is for paid subscribers

Already a paid subscriber? Sign in
© 2025 Nava Whiteford
Privacy ∙ Terms ∙ Collection notice
Start writingGet the app
Substack is the home for great culture

Share